Technologies Available for Partnering
Our commitment to innovative research spans a wide spectrum of technologies. From uncovering novel therapeutic targets and pioneering precise diagnostics platforms to harnessing the power of artificial intelligence to expedite the pace of discovery, we push the boundaries of what’s possible in the fight against cancer and related disease.
Showing 13-24 of 54
T-Cell Receptors (TCRs) that Recognize and Eliminate Melanoma Cells
- Collaboration
- Licensing
Engineering Bacteria To Enhance Cytokine Activity in Immunotherapy Response
- Collaboration
- Licensing
TEAD Inhibitors for the Treatment of Hippo Pathway-Dependent Cancers
- Collaboration
- Licensing
Degradation of RPN13 for Treatment of Multiple Myeloma
- Collaboration
- Licensing